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HIF-1-mediated suppression of 
mitochondria electron transport 
chain function confers resistance to 
lidocaine-induced cell death
Akihisa Okamoto1,2, Chisato Sumi1,2, Hiromasa Tanaka2, Munenori Kusunoki1,2, Teppei Iwai1, 
Kenichiro Nishi1, Yoshiyuki Matsuo2, Hiroshi Harada3,4, Keizo Takenaga5, Hidemasa Bono  6 
& Kiichi Hirota  2
The local anesthetic lidocaine induces cell death by altering reactive oxygen species (ROS) generation 
and mitochondrial electron transport chain function. Because hypoxia-inducible factor 1 (HIF-1) 
is involved in determining oxygen metabolism and mitochondria function, we investigated the 
involvement of HIF-1 activity in lidocaine-induced cell death. We investigated the role of HIF activation 
on lidocaine-induced caspase activation and cell death in renal cell-derived RCC4 cells lacking functional 
von Hippel-Lindau (VHL) protein. We demonstrate that HIF-1 suppressed oxygen consumption and 
facilitated glycolysis in a pyruvate dehydrogenase kinase-1-dependent manner and that activation of 
HIF-1 conferred resistance to lidocaine-induced cell death. We also demonstrated that exogenous HIF-1 
activation, through HIFα-hydroxylase inhibition or exposure to hypoxic conditions, alleviates lidocaine 
toxicity by suppressing mitochondria function and generating ROS, not only in RCC4 cells, but also in 
the neuronal SH-SY5Y cells. In conclusion, we demonstrate that HIF-1 activation due to VHL deletion, 
treatment with small molecule HIFα-hydroxylase inhibitors, and exposure to hypoxic conditions 
suppresses mitochondrial respiratory chain function and confers resistance to lidocaine toxicity.
Local anesthetics, including lidocaine, affect the intra- and extra-cellular signaling pathways of both neuronal 
and non-neuronal cells, resulting in long-term modulation of biological functions such as cell growth and death1. 
Although the primary target of lidocaine is voltage-gated sodium channels, the targets and mechanisms in the 
context of cell growth and death are unknown. Studies indicate that mitochondria are one of the critical targets 
of lidocaine2–4. Similarly, we previously reported that reactive oxygen species (ROS) derived from mitochondria 
play an essential role in lidocaine-induced apoptosis and treatment with the antioxidants N-acetyl cysteine (NAC) 
and Trolox effectively prevents apoptosis4. The mitochondrial oxidative phosphorylation (OXPHOS) system plays 
a critical role in modulating ATP supply in the human body. Deficits derived from genetic and pharmacologic 
treatments cause functional disorders and cell death. The OXPHOS machinery consists of four enzyme com-
plexes in the respiratory chain that transport electrons obtained from the oxidation of carbohydrates and fats to 
molecular oxygen (O2); a fifth enzyme complex uses the energy derived from this process to drive ATP synthesis. 
O2 is the electron acceptor, resulting in the production of H2O in a process that is catalyzed by complex IV of the 
mitochondrial electron transport chain (ETC). Because the process is not completely efficient, electron transport 
to O2 may occur in complexes I or III, resulting in generation of ROS that can oxidize cellular proteins, lipids, and 
nucleic acids5–7. The generated ROS causes cell dysfunction or death when cells are exposed to drugs affecting 
electron transport in the ETC.
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The hypoxia-inducible factors (HIFs) HIF-1 and HIF-2 are transcriptional factors that function as a master 
regulators of oxygen homeostasis in most animal species8–11. Previous studies demonstrated that HIF-1 transac-
tivates genes encoding glucose transporters, glycolytic enzymes, and the pyruvate dehydrogenase kinase PDK-1 
in response to reduced O2 availability12, 13. Each HIF is a heterodimeric protein composed of a constitutively 
expressed HIF-1β subunit and an O2-regulated HIF-1α or HIF-2α subunit14. Under aerobic or normoxic con-
ditions, HIF-1α and HIF-2α are subjected to prolyl hydroxylation by oxygenases that utilize O2 as a substrate9.
Hydroxylation modification is required for binding of the von Hippel-Lindau (VHL) protein, which targets 
HIF-1α and HIF-2α for ubiquitination and proteasomal degradation15. The interaction of HIFα with the coac-
tivators CBP and p300 is blocked by O2-dependent asparaginyl hydroxylation mediated by the factor inhibiting 
HIF-1 (FIH-1) protein16, 17. Under hypoxic conditions, the hydroxylation reaction rate declines because of a short-
age in substrate O2 molecules leading to HIF activation and providing a mechanism by which changes in oxygen-
ation are transduced to the nucleus as changes in gene expression. Even under normoxic conditions, treatment 
with hydroxylase inhibitors such as dimethyloxaloylglycine (DMOG), desferoxamine (DFX), and n-propyl gallate 
(nPG) activate HIFs14, 18, 19. Moreover, certain types of mutations and the genetic deletion of VHL also activate 
HIFs even under normoxic conditions18, 20.
HIFs drive hypoxic gene expression changes that are thought to be adaptive for cells exposed to a 
reduced-oxygen environment. Mitochondrial function can be regulated by HIFs12, 13, 21, 22. OXPHOS is regulated 
by several mechanisms, including substrate availability. The major substrates for OXPHOS are O2, which is the 
terminal electron acceptor, and pyruvate, which is the primary carbon source. Pyruvate is the end product of gly-
colysis and is converted to acetyl-CoA through the activity of the pyruvate dehydrogenase complex of enzymes 
that is regulated by pyruvate dehydrogenase kinases (PDKs)12. The acetyl-CoA directly enters the tricarboxylic 
acid cycle (TCA) cycle as citrate synthase where it combines with oxaloacetate to generate citrate. Thus, HIF-1 
not only regulates the supply of oxygen, but also actively regulates the oxygen demand of the tissues and cells by 
reducing the activity of the major cellular consumer of oxygen, mitochondria22. HIF-1 promotes the efficient 
use of available oxygen while also reducing the generation of harmful byproducts from respiration such as free 
radicals and H2O223, 24.
In this study, we investigate the role of HIF activation on lidocaine-induced apoptosis in renal cell-derived 
RCC4 cells lacking functional VHL and neuronal SH-SY5Y cells exposed to nPG, DFX, or hypoxia and describe 
that activation of HIF-1 alleviates lidocaine toxicity by suppressing mitochondrial functions and generating ROS.
Results
RCC4-EV cells are more resistant to lidocaine-induced cell injury than RCC4-VHL 
cells. RCC4-EV cells lack VHL activity and constitutively express HIF-1α and HIF-2α proteins, whereas in 
the RCC4-VHL subclone, which is stably transfected with a VHL expression vector, the expression of HIF-1α 
and HIF-2α proteins are induced only under hypoxic culture conditions20, 25. In order to determine the dose-re-
sponse relationship for caspase 3/7 activation, we treated RCC4-VHL cells with the indicated doses of lidocaine 
(Supplementary Fig. 1a). Both RCC4-VHL and RCC4-EV cells were exposed to 1, 4, and 10 mM lidocaine for 12 h 
and the caspase 3/7 (Fig. 1a) and caspase 9 (Fig. 1b) activity was evaluated. Next, time-response relationship was 
detemined for the indicated times (Fig. 1c). Concentrations higher than 4 mM lidocaine induced caspase activa-
tion within 12 h, and 4 mM lidocaine induced the activation in a time-dependent manner up to 48 h.
A significant difference was detected between RCC4-EV cells and RCC4-VHL cells following 4 mM and 
10 mM lidocaine treatment. To confirm these findings, RCC4-EV cells and RCC4-VHL cells were stained with 
PI and FITC-conjugated annexin V and evaluated by flow cytometry (Fig. 1d and Supplementary Fig. 1b). In 
agreement with the activation of caspase 3/7 and caspase 9, cell death rates following treatment with 1 mM and 
4 mM lidocaine for 12 h were significantly less in RCC4-EV cells than in RCC4-VHL cells. The 10 mM lidocaine 
treatment increased the PI positive cell population, whereas the component ratios were not different between the 
cell types (Fig. 1d). Although there was a significant difference between RCC4-VHL cells and RCC4-EV cells in 
the lactate dehydrogenase (LDH) release induced by 4 mM lidocaine treatment, a significant difference was not 
detected following treatment with 10 mM lidocaine (Fig. 1e).
Finally, the mitochondria membrane voltage (ΔΨm) was investigated in both cell lines (Fig. 1f and 
Supplementary Fig. 1c). The decrease in ΔΨm by 1 mM and 4 mM lidocaine treatment was prevented in 
RCC4-EV cells. In contrast, a statistically significant difference was not detected following 10 mM lidocaine 
treatment.
Together, the experimental results indicate that RCC4-EV cells are more resistant to 4 mM lidocaine-induced 
apoptosis compared to its derivative RCC4-VHL, in which VHL protein are exogenously overexpressed.
HIFs are activated in RCC4-EV cells under 20% O2 conditions. We investigated whether the HIFs are 
active in RCC4-VHL and RCC4-EV cells in normoxic (20% O2) and hypoxic (1% O2) conditions. First, expres-
sion of HIF-1α, HIF-2α, and HIF-1β proteins were assayed by Western blot analysis in RCC4-VHL cells and 
RCC4-EV cells under both 20% and 1% O2 conditions (Fig. 2a). Consistent with a previous report20, HIF-1α and 
HIF-2α proteins were constitutively expressed even under 20% O2 conditions in RCC4-EV cells at comparable 
levels to those of RCC4-VHL cells under 1% O2 conditions. HIF-1β expression was stable for both oxygenation 
states in both cell types. Consistent with HIF-α protein expression, glucose transporter 1 (glut1), lactate dehy-
drogenase A (ldha), and PDK-1 mRNA had increased expression in RCC4-EV cells than in RCC4-VHL cells 
under 20% O2 conditions. In contrast, HIF-1α and HIF-2α mRNA expression patterns are different from those 
of HIF-downstream gene expressions (Fig. 2b). Notably, RCC4-EV cells under 20% O2 conditions had decreased 
HIF-1α mRNA expression levels compared to RCC4-VHL cells under 1% O2 conditions (Fig. 2b).
Next, the RCC4-EV and RCC4-VHL cell proliferation rates were measured using an assay based on 
reduction of the tetrazolium compound [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfoph
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enyl)-2H-tetrazolium, inner salt; MTS] (Fig. 2c). No significant difference in cell proliferation rates between 
RCC4-VHL cells and RCC4-EV cells was found. However, the ATP content in RCC4-EV cells was higher 
than that in RCC4-VHL cells (Fig. 2d). There were no significant differences in mitochondrial mass between 
RCC4-VHL cells and RCC4-EV cells (Fig. 2e).
The transcription factors HIF-1 and HIF-2 were constitutively activated in RCC4-EV, which lacks VHL gene 
even under 20% O2 as comparably as those of RCC4-VHL cells under 1% O2 conditions.
HIF-1 activation is required for RCC4-EV cells to confer resistance to lidocaine-induced cell 
death. HIFs, including HIF-1 and HIF-2, are activated in RCC4-EV cells under 20% O2 conditions. We 
next examined the involvement of HIFs in maintaining the resistance to lidocaine toxicity. RCC4-EV cells were 
treated with the HIF inhibitor YC-1. The YC-1 treatment decreased expression of genes located downstream 
from HIF-1 and HIF-2 (Supplementary Fig. 2a). The YC-1 treatment significantly increased caspase3/7 acti-
vation (Fig. 3a) and induced cell death (Fig. 3b) within 12 h following 4 mM lidocaine treatment in RCC4-EV 
cells. In contrast, the treatment with YC-1 did not exert a significant effect on caspase3/7 activation or cell death 
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Figure 1. RCC4-EV cells are more resistant to lidocaine-induced cell injury than RCC4-VHL cells. RCC4-
VHL and RCC4-EV cells were exposed to the indicated concentrations (1, 4, or 10 mM) of lidocaine for 
varying lengths of time (0, 12, 24, and 48 h). (a,b and c) Graphic depictions of caspase-3/7 (n = 5) (a and b) 
and caspase-9 (n = 5) (c) activity in each treatment group at different time points (d) Cells were harvested and 
cell death percentages were measured with flow cytometry. The ratio of propidium iodide (PI)-positive and/or 
annexin V-positive cells [(Q1 + Q2 + Q4)/(Q1 + Q2 + Q3 + Q4)] was used to calculate the percentage of dead 
cells (Supplemental Fig. S1) (n = 3). (e) Graphic depiction of cell death percentages in treated and untreated cell 
populations. Cell death was evaluated by measuring the levels of lactate dehydrogenase (LDH) within culture 
supernatants (n = 4). Control is treatment with lysis buffer. (f) Graphic depiction of the average mitochondrial 
membrane potential (ΔΨm) of treated and untreated cells (n = 3) at each time point. Values indicate the 
ratio [Q2/(Q2 + Q4)] of green JC-1 monomers (527 nm emission) to red aggregates (590 nm emission). Data 
presented in (a–f) are expressed as mean ± standard deviation (SD). Differences between results were evaluated 
by two-way ANOVA followed by Dunnett’s test for multiple comparisons (a, c–f) or one-way ANOVA followed 
by Dunnett’s test for multiple comparisons (b). *p < 0.05 compared to the control cell population at incubation 
time 0 h (no treatment). #p < 0.05 compared to the control cell population at the same lidocaine concentration 
(group).
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inhibitors nPG (100 µM) and DFX (130 µM) in addition to exposure to the 1% O2 condition. These treatments 
increased expression of genes located downstream of HIF-1 and HIF-2 (Supplementary Fig. 2c) and conferred 
lidocaine resistance in RCC4-VHL cells. The treatments significantly suppressed caspase3/7 activation (Fig. 3c) 
and inhibited cell death (Fig. 3d) induced by 4 mM lidocaine in RCC4 cells. Thus, the evidence indicates that 
HIF activation is required and sufficient for maintenance of resistance against lidocaine toxicity. Because genetic 
ablation or treatment with HIFα hydroxylase inhibitors including nPG and DFX activate both HIF-1 and HIF-2 
transcription factors19, 20, we examined which subtype is critical for conferring lidocaine resistance. Both the 
mRNA and protein expressions of HIF-1α or HIF-2α was were decreased decerased significantly by treatment 
treament with the corresponding siRNA (Fig. 3e) and HIFα proteins (Supplementary Fig. 2d). The knockdown 
study indicated that suppression of HIF-1α expression, but not HIF-2α, significantly affected caspase 3/7 activa-
tion (Fig. 3f) and cell death rates (Fig. 3g) following 4 mM lidocaine treatment. The results indicate that HIF-1, 
but not HIF-2, plays an essential role in the phenomenon.
Thus, HIF-1 but not HIF-2 activity is required for RCC4-EV cells to be resistant to lidocaine-induced cell 
death.
Figure 2. HIFs are activated in RCC4-EV cells in normoxic conditions. (a) RCC4-EV and RCC4-VHL 
cells were exposed to normoxic (20% O2) or hypoxic (1% O2) conditions for 4 h. Whole-cell lysates were 
immunoblotted (IB) using anti-HIF-1α, HIF-2α, HIF-1β, and β-actin antibodies. Experiments were repeated 
twice and representative blots are shown. (b) RCC4-EV and RCC4-EV cells were cultured for 4 h under 20% 
O2 or 1% O2 conditions prior to analysis of hypoxia-inducible factor 1α (hif1α), hypoxia-inducible factor 2α 
(hif2α), hypoxia-inducible factor 1β (hif1β), glucose transporter 1 (glut1), lactate dehydrogenase A (lhda), 
and pyruvate dehydrogenase kinase 1 (pdk1) mRNA levels using real-time reverse transcriptase polymerase 
chain reaction (RT-PCR). Fold expression was calculated relative to the values measured for RCC4-VHL cells 
incubated in 20% O2. Data presented are expressed as mean ± standard deviation (SD). *p < 0.05 compared to 
the control cell population of RCC4-VHL cells under 20% O2 conditons. #p < 0.05 compared between indicated 
groups. (c) Graphic depiction of the cell viability levels for treated and untreated cells at each time point 
(n = 4). Differences between results were evaluated by two-way ANOVA followed by Dunnett’s test for multiple 
comparisons. (d) ATP content of RCC4-EV and RCC4-VHL cells was measured. Differences between results 
were evaluated by t-test. #p < 0.05 compared between indicated groups. (e) Equal numbers of RCC4 and RCC4-
VHL cells were stained with MitoGreenTM and analyzed by flow cytometry to measure mitochondrial mass. 
Differences between results were evaluated by t-test.
www.nature.com/scientificreports/
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Figure 3. HIF-1 activation is required for RCC4-EV cells to confer resistance against lidocaine-induced 
cell death. (a and b) RCC4-EV cells were exposed to 4 mM lidocaine for 24 h with or without 100 µM YC-1. 
(a) Graphic depictions of caspase-3/7 activity (n = 5). (b) Cells were harvested and cell death percentages 
were analyzed by flow cytometry. (c and d) RCC4-VHL cells were exposed to 4 mM lidocaine and treated 
with 100 µM nPG, 100 µM DFX, or exposure to 1% O2 conditions for 24 h. Graphic depictions of caspase-3/7 
activity (n = 5). (c) Cells were harvested and cell death percentages were analyzed by flow cytometry. (d) (e–g) 
RCC4-EV cells were transfected with small interfering RNA (siRNA) targeting HIF-1α (hif1a), HIF-2α (hif2a), 
or a negative control (scr). Expression of mRNA of HIF-1α, HIF-2α was measued by qRT-PCR. (e) Cells were 
exposed to 4 mM lidocaine for 24 h. Graphic depictions of caspase-3/7 activity (n = 5). (f) Cells were harvested 
and cell death percentages were analyzed by flow cytometry. (g) Data presented in (a–g) are expressed as 
mean ± standard deviation (SD). Differences between results were evaluated by two-way ANOVA followed by 
Dunnett’s test for multiple comparisons. *p < 0.05 compared to the control cell population at incubation time 
0 h (no treatment). #p < 0.05 compared to the indicated experimental group.
www.nature.com/scientificreports/
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Reprogrammed oxygen metabolism is established in RCC4-EV cells. Because numerous reports 
clearly indicate HIF-1 involvement in determination of oxygen metabolism12, 13, 21, 24, 26, we investigated gene 
expression in RCC4-EV cells and RCC4-VHL cells by RNA-Seq analysis using data deposited in a public data-
base. The RNA expression analysis by Next-Generation Sequencing (NGS) data revealed differences in the cellu-
lar hypoxic pathway and HIF-1-signaling pathway between RCC4-EV cells and RCC4-VHL cells (Supplementary 
Fig. 3a and b and Supplementary Table 1). Next, we investigated oxygen metabolism activity and glycolysis in 
RCC4-EV cells and RCC4-VHL cells using the oxygen consumption rate (OCR) (Fig. 4a and Supplementary 
Fig. 4a and c) and extracellular acidification rate (ECAR), which is a surrogate index for glycolysis (Fig. 4b and 
Supplementary Fig. 4b and d). The mitochondrial basal oxygen consumption rate (OCR-basal) was significantly 
lower in RCC4-EV cells than in RCC4-VHL cells under 20% O2 conditions (Fig. 4a). In accordance, ECAR levels, 
representing extracellular lactate concentration, were significantly higher in RCC4-EV cells than in RCC4-VHL 
cells (Fig. 4b). In addition, there were significant differences in maximum respiratory rate, non-mitochondrial 
respiration, and proton leak between RCC4-EV cells and RCC4-VHL cells (Supplementary Fig. 4e–g) and the 
reprogramming is suppressed by YC-1 treatment (Supplementary Fig. 5a). Thus, oxygen and metabolic repro-
gramming from aerobic to anaerobic glucose metabolism occurred in RCC4-EV cells. Moreover, nPG treatment, 
DFX treatment, or 1% O2 exposure conditions also metabolically reprogrammed RCC4-VHL-cells (Fig. 4c and 
d). Next, the involvement of mitochondria function in lidocaine-induced toxicity was investigated. P29 cells are 
an established cell line derived from mouse lung cancer. P29 ρ0 cells are a subclone lacking mitochondria DNA 
(Supplementary Fig. 5b). Both 4 and 10 mM lidocaine induced caspase 3/7 activation (Fig. 4e) and cell death rates 
(Fig. 4f) assayed using FACS in P29 cells, similar to RCC4-VHL cells. In contrast, P29 ρ0 cells are almost resistant 
to the effects induced by 4 and 10 mM lidocaine (Fig. 4e and f).
The experimental results indicated the HIF-1 activation is required and sufficient to reprogram the oxygen 
metabolism in a mitochondria-dependent manner in RCC4 cells.
ROS production in response to lidocaine treatment is reduced in RCC4-EV cells in a PDK-
1-dependent manner. In a previous study4, we found that lidocaine induces reactive oxygen species (ROS) 
generation in cells and that ROS play a critical role in lidocaine-induced cell death. Here, we compared ROS 
generation between RCC4-VHL and RCC4-EV cells in response to 4 mM lidocaine treatment. ROS genera-
tion in response to 4 mM lidocaine treatment increased in RCC4-VHL cells, but did not significantly change in 
RCC4-EV cells (Fig. 5a). PDK-1 expression is responsible for the reduction in ROS generation under hypoxic 
conditions23, 24 and the metabolic switch for cellular adaptation to hypoxia12, 13. mRNA expression of PDK-1 was 
decreased significantly by treatment with the siRNA (Fig. 5b). The reduction of ROS generation in RCC4-EV cells 
was reversed by suppression of PDK-1 expression by treatment with siRNA against PDK-1 (Fig. 5c). Accordingly, 
caspase 3/7 activation by 4 mM lidocaine is increased in RCC4-EV cells treated with siRNA against PDK-1 
(Fig. 5d). Although the OCRs were not significantly affected by treatment with siRNA against PDK-1 (Fig. 5e), 
ECAR in RCC4-EV cells was suppressed (Fig. 5f).
Thus, ROS production in response to lidocaine treatment is reduced in RCC4-EV cells in a PDK-1-dependent 
manner. Suppression of ROS generation results in survival of cells against lidocaine treatment.
HIF-1 activation is sufficient to resist lidocaine toxicity in neuronal SH-SY5Y cells. Finally, we 
tested whether exogenous HIF-1 activation confers resistance to lidocaine in cells derived from different origins 
than RCC4 cells. The neuronal SH-SY5Y cells were treated with 100 µM nPG or 130 µM DFX in 20% O2 or exposed 
to 1% O2 for 6 h. The treatment increased HIF-1α protein expression (Fig. 6a), suppressed OCR, and increased 
ECAR (Fig. 6b) in SH-SY5Y cells and induced expression of HIF-1α-target genes (Supplementary Figure 6). As in 
RCC4-VHL cells, treatment with nPG or DFX conferred resistance to 4 mM lidocaine-induced caspase 3/7 activa-
tion (Fig. 6c) and cell death rates assayed with PI/Annexin V staining (Fig. 6d). In addition to the treatment with 
nPG and DFX, exposure to 1% O2 also conferred lidocaine resistance to SH-SY5Y cells (Fig. 6c and d).
Thus, HIF-1 activation by treatment with HIFα-hydroxylase inhibitors and exposure to hypoxia also sufficient 
to be resistant against lidocaine toxicity to cells even derived from neuronal origin.
Discussion
In this study, we demonstrated for the first time that activation of the endogenous transcription factor HIF-1 
attenuated ROS generation and cell death elicited by lidocaine in not only RCC4 cells, the established renal carci-
noma cell line, but also SH-SY5Y cells, a neuronal cell line.
Although the primary target of lidocaine as a local anesthetic is the voltage-gated sodium channels1, lido-
caine affects cell growth and cell death by modulating mitochondria function at clinically relevant concentra-
tions. Our experimental results utilizing P29 ρ0 cells that lack mitochondria DNA (Fig. 4e and f) clearly indicate 
mitochondria play a critical role in lidocaine-induced apoptosis but not necrosis2–4. We recently demonstrated 
that the local anesthetic lidocaine suppresses the mitochondrial ETC in neuronal SH-SY5Y cells in a dose- and 
time-dependent manner, thereby attenuating mitochondrial membrane potential, inducing ROS production, and 
activating caspase-9- and caspase-3/7-mediated apoptosis and necrosis4. Genetic deletion of VHL gene results in 
activation of HIFs, including HIF-1 and HIF-2, as demonstrated in Fig. 2a and Supplementary Figure 3. VHL is 
an essential component of the E3 ubiquitin ligase that plays an essential role in regulation of HIFα subunit protein 
expression in response to ambient oxygen concentrations. Thus, in RCC4-EV cells, HIF-1α and HIF-2α pro-
teins are expressed even under 20% oxygen concentrations20. VHL deletion conferred resistance against 1-4 mM 
lidocaine-induced apoptosis and overexpression of VHL in RCC4 cells made cells sensitive to lidocaine toxicity 
(Figs 1 and 3). Although both HIFs are structurally and functionally similar, HIF-1 and HIF-2 exert distinct 
roles27, 28. In Fig. 3f, the differential suppression of f HIF-1α and HIF-2α mRNA with siRNA indicate that HIF-1, 
rather than HIF-2, plays a dominant and critical role in conferring the resistance to lidocaine-induced apoptosis. 
www.nature.com/scientificreports/

























































































Figure 4. Reprogrammed oxygen metabolism is established in RCC4-EV cells. Oxygen consumption rate 
(OCR) (a and c) and extracellular acidification rate (ECAR) (b and d) in RCC4-EV cells and RCC4-VHL 
cells (a and b) in normoxic (20% O2) conditions and RCC4-VHL cells exposed to nPG, DFX, or hypoxic (1% 
O2) conditions (c and d). P29 cells and P29 ρ0 cells were exposed to the indicated lidocaine dose for 24 h (e 
and f). Graphic depiction of caspase-3/7 activity (n = 5) (e). Cells were harvested, and the levels of cell death 
percentages were analyzed by flow cytometry. The ratio of propidium iodide (PI)-positive and/or annexin 
V-positive cells [(Q1 + Q2 + Q4)/(Q1 + Q2 + Q3 + Q4)] was used to calculate the percentage of dead cells 
(Supplemental Fig. S1) (n = 3) (f). Cells were harvested, and the levels of cell death were analyzed by flow 
cytometry (f). The ratio of propidium iodide (PI)-positive and/or annexin V-positive cells [(Q1 + Q2 + Q4)/
(Q1 + Q2 + Q3 + Q4)] was used to calculate the percentage of dead cells (n = 3). Data presented in (a–f) are 
expressed as means ± standard deviations (SD). Differences between results were evaluated by the t-test (a and 
b), one-way ANOVA (c and d) followed by Dunnett’s test for multiple comparisons (c and d), and two-way 
ANOVA (e and f) followed by Dunnett’s test for multiple comparisons (e and f). *p < 0.05 compared to the 
control cell population. #p < 0.05 compared to the indicated experimental groups.
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This is consistent with the reports that HIF-1 is preferentially involved in metabolic regulation, especially glucose 
metabolism12, 13, 29, 30. Both RT-PCR assay (Fig. 2b) and RNA-Seq analysis (Supplementary Figure 3b) reveal that 































































































Figure 5. ROS production in response to lidocaine treatment is reduced in RCC4-EV cells in a PDK-1-
dependent manner. (a) Graphic depiction of reactive oxygen species (ROS) production in RCC4-VHL cells 
and RCC4-EV cells exposed to 4 mM lidocaine (n = 3). Data depict the ratio of ROS production in treated 
cells to compared to that in the mean value of RCC4-VHL cells without lidocaine treatment. RCC4-EV cells 
were transfected with small interfering RNA (siRNA) targeting pyruvate dehydrogenase kinases 1 (PDK-1) or 
a negative control (scr). (c) ROS production during treatment with 4 mM lidocaine was assayed. (d) Graphic 
depictions of caspase-3/7 activity (n = 5). The cellular oxygen consumption rate (OCR) (e) and extracellular 
acidification rate (ECAR) (f) were measured. Data presented in (a–f) are expressed as mean ± standard 
deviation (SD). Statistical differences between results were evaluated using the t-test (a,d and e) or two-way 
ANOVA followed by Dunnett’s test for multiple comparisons (b–d). *p < 0.05 compared to the control cell 
population. #p < 0.05 compared to the indicated experimental groups.
www.nature.com/scientificreports/
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cells. Although the exact molecular mechanism behind the phenomenon is to be investigated, this may be due to 
the negative feed back loop.
The primary purpose of OXPHOS is the transfer of electrons through a series of cytochromes in order to 
make a proton gradient across the inner mitochondrial membrane. The potential energy of the proton gradient 
is utilized to synthesize ATP by ATP synthases. O2 is the electron acceptor, resulting in the production of H2O 
in a process that is catalyzed by cytochrome c oxidase (COX; complex IV). COX4 has two isoforms: COX4I1 
and COX4I2. HIF-1 upregulates COX4I2 expression and activates the LON mitochondrial protease, which in 
turn degrades COX4I121. This mechanism is part of the molecular machinery for preserving ATP production in 
RCC4-EV cells. In accordance with the evidence, the basal OCR of RCC4-EV is lower than that of RCC4-VHL 
(Fig. 4a). In addition, the Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP)-stimulated maximal 
respiration rates in RCC4-EV cells are decreased less than in RCC4-VHL cells (Supplementary Fig. 4e). Together, 
the evidence strongly suggests that the mitochondrial ETC in RCC4-EV cells is significantly inhibited compared 
to in RCC4-VHL cells. However, the mitochondrial mass and the mitochondrial membrane potential are equiv-
alent in each cell line (Fig. 2e).
The ATP content was higher in RCC4-EV cells than in RCC4-VHL cells (Fig. 2d). Thus, as demonstrated by 
the significant difference in ECAR between RCC4-EV and RCC4-VHL cells, glycolysis in RCC4-EV cells is ele-
vated to compensate for the suppression of OXPHOS. ATP production efficiency in RCC4-EV cells, defined as a 
decrease in OCR after treatment with the complex V inhibitor oligomycin, is lower than that in RCC4-VHL cells 
(Fig. 2e). Proton leak, as defined by the mitochondrial respiration rate in the presence of oligomycin, is appar-
ent in RCC4-EV and RCC4-VHL cells (Supplementary Fig. 4g). Since mitochondrial superoxide production is 
steeply dependent on Δp, proton leak pathways may exist to minimize oxidative damage by tempering Δp and 
mitochondrial superoxide production31–33.
OXPHOS is regulated by several mechanisms, including substrate availability. The major substrate for 
OXPHOS is O2. Pyruvate is the product of glycolysis and is converted to acetyl-CoA through the activity of the 
pyruvate dehydrogenase complex of enzymes. Acetyl-CoA is another OXPHOS regulating factor. Acetyl-CoA 
directly enters the TCA cycle. The conversion of pyruvate to acetyl-CoA represents a critical regulatory point in 








































































Figure 6. HIF-1 activation is sufficient to resist lidocaine toxicity in neuronal SH-SY5Y cells. (a) SH-SY5Y 
cells were exposed to 100 µM nPG, 100 µM DFX, or 1% O2 for 4 h. Whole-cell lysates were immunoblotted (IB) 
using anti-HIF-1α, HIF-1β, or β-actin antibodies. Experiments were repeated twice and representative blots 
are shown. (b) Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of SH-SY5Y cells 
exposed to 100 µM nPG, 100 µM DFX, or 1% O2 for 6 h were measured. (c) SH-SY5Y cells were exposed to 
4 mM lidocaine and 100 µM nPG, 100 µM DFX, or 1% O2 for 24 h. Graphic depictions of caspase-3/7 activity 
(n = 5). (d) SH-SY5Y cells were exposed to 4 mM lidocaine and 100 µM nPG, 100 µM DFX, or 1% O2 for 24 h. 
Cells were harvested and cell death percentages were analyzed by flow cytometry (n = 3). *p < 0.05 compared to 
the control cell population. #p < 0.05 compared to the indicated experimental groups.
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36. PDK1 is a HIF-1 downstream product that negatively regulates the function of the mitochondria by reducing 
pyruvate entry into the TCA cycle. By excluding pyruvate from mitochondrial consumption, PDK1 induction 
may increase the conversion of pyruvate to lactate, which is then shunted to the extracellular space, regenerating 
NAD for continued glycolysis. Several reports have also suggested a link between altered mitochondrial func-
tion in hypoxia and HIF activation5–7. Thus, HIF target gene activation is upstream of mitochondrial function, 
and responsible for altering mitochondrial activity in RCC4-EV cells12, 13, 22. The transcription factors HIF-1 and 
HIF-2 are identified to regulatory factors for a line of genes involving in intracellular metabolic regulation such 
as glycolysis and mitochondrial metabolism. In fact, a series of glycolytic enzyme such as glut1 and enzymes in 
TCA cycle such as isocitrate dehydrogenase 2 (IDH2) are reported to be induced under hypoxic conditions in a 
HIF-1-dependent manner in human umbilical vein endothelial cells. However, as indicated in our RNA-Seq anal-
ysis revealed that mRNA expression of IDH1, IDH2 or IDH3 was not significantly different between RCC4-EV 
cells and RCC4-VHL cells (gene_exp. diff, Supplementary Dataset S1). The evidence strongly suggests that these 
enzymes do not play a critical role in metabolic reprogramming and cell resistance to lidocaine-induced apop-
tosis. In contrast, expression of a line of glycolysis-related proteins including glut1 increases in RCC4-EV cells 
compared to RCC4-VHL cells.”
Previous reports and our recent findings indicate that both lidocaine-induced apoptosis and necrosis are 
ROS-dependent37. We recently demonstrated that lidocaine treatment induced ROS generation4. As such, these 
data imply that lidocaine-mediated cell death is dependent on mitochondrial function. Consistent with this con-
clusion, the mitochondrial DNA-deficient ρ0 cells were resistant to lidocaine treatment (Fig. 4e and f). O2 is the 
electron acceptor, resulting in the production of H2O in a process that is catalyzed by complex IV. Because the 
process is not completely efficient, electron transfer to O2 may occur at complex I or III, resulting in ROS gen-
eration, which oxidizes cellular proteins, lipids, and nucleic acids5, 6, 38. Lidocaine-induced ROS production in 
RCC4-EV cells is significantly less than in RCC4-VHL cells. Thus, HIF target gene activation is upstream of mito-
chondrial function and is responsible for altering mitochondrial activity. ROS generation in cancer cells occurs in 
a HIF-1-mediated metabolic reprogramming-dependent manner39.
In addition to regulation of HIF activity by VHL molecules, small chemical compounds activate HIFs by 
interfering the cellular HIFα hydroxylase systems9. We used two small chemical compounds, nPG competitive 
inhibition of 2-oxoglutarate19 and DFX essential cofactor Fe2+ chelate9, 14. nPG and DFX induced HIF-1α protein 
expression within 3 h (Fig. 6a). In accordance with the induction of HIF-1 activation, OCR decreased and ECAR 
increased within 6 h. The evidence indicates that not only continuous activation, but also transient activation of 
HIF-1 is sufficient to exert the metabolic reprogramming from OXPHOS to glycolysis and the reprogramming 
and mitochondria suppression are sufficient to prevent lidocaine-induced cell apoptosis. We also demonstrate 
that not only RCC4 cells derived from clear cell kidney carcinoma, but also the neuronal SH-SY5Y cells can 
acquire the lidocaine toxicity resistance.
Reduced oxygen availability elicited by hypoxia and mitochondrial dysfunction leads to increased produc-
tion of ROS by the electron transport chain. As demonstrated in this study, HIF-1 mediates adaptive metabolic 
responses to electron transport chain, including increased flux through the glycolytic pathway and decreased 
flux through the tricarboxylic acid cycle, in order to decrease mitochondrial ROS production (Fig. 7). HIF‐1 
is also involved in mitochondrial one‐carbon (folate cycle) metabolism to increase mitochondrial antioxidant 
production (NADPH and glutathione). Thus, dynamic maintenance of ROS homeostasis is dependent on HIF-1. 
Recently, it was reported that VHL-deletion rescues the retardation of cell growth elicited by antimycin, a complex 
III inhibitor in the mitochondrial respiratory chain40. Interestingly, HIF-1 activation is necessary and sufficient 
for the phenomenon. In addition to the established cell lines, HIF-1 activation by chemical HIFα-hydroxylase 
Figure 7. The schematic representation of the findings of this study. HIF-1α- induced PDK1 sequesters 
glucose metabolite flux from the mitochondria to glycolysis. This glycolytic shift redirects the metabolic flux 
to compensate the suppression of mitochondrial activity by lidocaine to reduce ROS generation and maintain 
intracellular ATP contents. LDHA: lactate dehydrogenase A, PDH: pyruvate dehydrogenase, PDK1: pyruvate 
dehydrogenase kinase, ROS: reactive oxygen species.
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inhibitor and exposure to hypoxic environments allows survival in zebrafish treated by antimycin and in a mouse 
model of Leigh syndrome harboring deletion of Ndufs4, a structural subunit in the mitochondrial complex I41.
In conclusion, we demonstrate that HIF-1 activation due to VHL deletion, treatment with small molecule 
HIFα-hydroxylase inhibitors, and exposure to hypoxic conditions suppresses mitochondrial respiratory chain 
function and confers resistance to lidocaine toxicity (Fig. 7).
Methods
Cell culture and reagents. The renal cell carcinoma cell lines stably transfected with pcDNA3-VHL 
(RCC4-VHL) or empty vector (RCC4-EV) were maintained in DMEM supplemented with 10% FBS, 100 U/ml 
penicillin, and 0.1 mg/ml streptomycin25. Human neuroblastoma SH-SY5Y cells were maintained in RPMI 1640 
medium that contained 10% FBS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin4. n-propyl gallate (nPG), des-
feroxamine (DFX), and the anti-β-actin antibody (Ab) were obtained from Sigma (St. Louis, MO, USA). Purified 
mouse anti-human HIF-1α Ab Clone 54/HIF-1α was purchased from BD Biosciences (San Jose, CA, USA). 
Anti-HIF-2α (NB100-122) Ab was from Novus Biologicals (Littleton, CO, USA) and HIF-1β/ARNT (D28F3) XP 
rabbit mAb was from Cell Signaling Technology (Danvers, MA, USA).
Cell growth assay (MTS assay). Cell growth was assessed using a CellTiter 96TM AQueous One Solution 
Cell Proliferation Assay (Promega, Madison, WI, USA)4. Briefly, cells were cultured overnight in 96-well plates 
(2 × 104 cells/well) and treated with the reagents as indicated in the legend to each figure. Twenty μl of CellTiter 
96 AQueous One Solution was added to each well, and after 1 hour incubation the absorbance at 490 nm was 
recorded using an iMarkTM Microplate Reader (BIO-RAD, Hercules, CA, USA). All samples were tested 3 or 4 
times for each experiment.
Caspase assays. Caspase-3/7 and caspase-9 activities were assessed using an Apo-ONETM Homogeneous 
Caspase-3/7 Assay Kit (Promega) and a Caspase-GloTM 9 Assays Kit (Promega), respectively, following the man-
ufacturer’s instruction4. Briefly, cells were plated in 96-well plates (2 × 104 cells/well) and incubated overnight. 
Cells were then treated with the appropriate drug(s) for the indicated periods, and caspase activity was measured 
by adding 100 μl of Apo-One assay reagent to each well. The fluorescence of each sample was measured using an 
EnSpireTM Multimode Plate Reader (PerkinElmer, Waltham, MA, USA). Assays were performed in triplicate and 
repeated at least twice. Data were expressed as mean ± standard deviation (SD).
Immunoblot assays. Whole-cell lysates were prepared as described previously42–44 using ice-cold lysis 
buffer (0.1% SDS, 1% Nonidet P-40 [NP-40], 5 mM EDTA, 150 mM NaCl, 50 mM Tris-Cl [pH 8.0], 2 mM DTT, 
1 mM sodium orthovanadate, and Complete Protease InhibitorTM [Roche Diagnostics, Tokyo, Japan]). Samples 
were centrifuged at 10,000 × g to sediment the cell debris, and the supernatant was used for subsequent immu-
noblotting experiments. For HIF-α and HIF-1β determinations, 100 µg of protein was fractionated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (7.5% gel), transferred to membranes and immunoblotted 
using primary antibodies at a dilution of 1:1,000. Horseradish peroxidase-conjugated to sheep anti-mouse IgG 
(GE Healthcare, Piscataway, NJ, USA) was used as a secondary antibody at a dilution of 1:1,000. The signal was 
developed using enhanced chemiluminescence reagent (GE Healthcare). Experiments were repeated at least two 
times and representative blots are shown.
Analysis of cell death. Apoptotic cell death was determined using Annexin V-FITC Apoptosis Detection 
Kit (BioVision, Milpitas, CA, USA), as described previously4. Briefly, cells were plated in 6-well plates (3 × 105 
cells/well) the day prior to the assay. After overnight incubation, cells were treated with the indicated drug(s) 
for varying lengths of time and harvested by centrifugation at 260 × g for 3 min. The resulting cell pellets were 
resuspended in 500 μl binding buffer containing 5 μl of Annexin V-FITC and 5 μl of propidium iodide (PI; 50 μg/
ml), and stained for 5 min at 25 °C in the dark. Cells were analyzed using a FACSCalibur flow cytometer (BD 
Biosciences) equipped with CellQuest ProTM software. Data analysis was performed using FlowJoTM version 7.6.3 
software (TreeStar, Ashland, OR, USA), and the results were exported to Excel spreadsheets, subsequently ana-
lyzed with the statistical application Prism7TM.
Lactate dehydrogenase (LDH)-based cytotoxic assay. Cell cytotoxicity was measured using 
CytoTox-ONETM Kit (Promega) as described previoulsy4. Briefly, cells were cultured overnight in 96-well 
plates (2 × 104 cells/well) and treated with the indicated drug(s) for varying lengths of time. Twenty μl of 
CytoTox-ONETM reagent was added to each well and plates were incubated at 22 °C for 10 min. The reaction was 
terminated by adding 50 µl of Stop Solution, and the fluorescence was recorded with an excitation wavelength of 
560 nm and an emission wavelength of 590 nm using an EnSpireTM Multimode Plate Reader (PerkinElmer). The 
percentage of cell death was determined by comparing the release of LDH (fluorescence value) from each treat-
ment group with that of the positive control treated with Lysis solution, which was defined as 100%. Meanwhile, 
the value for LDH release from untreated cells (negative control) was defined as 0%. Each sample was assayed in 
triplicate.
Determination of mitochondrial membrane potential (ΔΨm). Mitochondrial membrane potential 
was assessed by flow cytometry with MitoPTTM JC-1 Assay Kit (ImmunoChemistry Technologies, Bloomington, 
MN, USA), according to the manufacturer’s instructions4. Cells were seeded in 6-well plates (3 × 105 cells/well) 
and cultured overnight. After treatment with the appropriate drug(s), cells were collected by centrifugation at 
260 × g for 3 min. Cell pellets were resuspended in JC-1 staining solution and incubated at 37 °C for 15 min in the 
dark. Samples were subsequently analyzed using a FACSCalibur flow cytometer (BD Biosciences) equipped with 
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CellQuest ProTM software for detecting JC-1 aggregates with red fluorescence (590 nm emission) or the mono-
meric form (green fluorescence; 527 nm emission). The data were evaluated using FlowJo version 7.6.3 software 
(TreeStar, San Carlos, CA, USA), and the results were exported to Excel spreadsheets, subsequently analyzed 
using the statistical application Prims7TM.
ATP assay. The CellTiter-GloTM luminescent cell viability assay Kit (Promega, Madison, WI) was used to 
evaluate the intracellular ATP content. Cells were seeded in 96-well plates. After 24 hours of attachment to the 
bottom of the plates, 50 μl of the CellTiter-Glo reagent was added directly into each well for a 10-minute incu-
bation. The plate was read by an EnSpireTM Multimode Plate Reader (PerkinElmer, Waltham, MA, USA) after 
incubation to monitor the luminescence signal generated by the luciferase-catalyzed reaction of luciferin and 
ATP. Assays were performed in triplicate at least twice. ATP content was then calculated by comparing the lumi-
nescence levels of RCC4-VHL cells with that of RCC4-EV cells, which was defined as 100%. Data were expressed 
as mean ± standard deviation (SD).
Gene silencing by siRNA. Cells were grown until 30–50% confluence prior to plating on a 
24-well plate using DMEM without antibiotics44. The cells were then transfected with Validated 
Stealth RNAi (100 pmol/mL) for HIF-1α (sense: 5′-GGAUGCUGGUGAUUUGGAUAUUGAAdTdT
- 3 ′ ,  a n t i s e n s e :  5 ′ - U U C A AUAU C C A A AU C AC C AG C AU C C d Td T- 3 ′ ) ,  H I F - 2 α  ( s e n s e : 
5′-CAGCAUCUUUGAUAGCAGUdTdT-3′ and antisense: 5′-ACUGCUAUCAAAGAUGCUGdTdT-3), or with 
the Stealth RNAi Negative Control Kit (Invitrogen Corp., Carlsbad, CA, USA) using Lipofectamine RNAiMAX 
(Invitrogen Corp.), according to the manufacturer’s instructions. Transfected cells were incubated in a normoxic 
incubator for 24 h following siRNA transfection.
Hypoxic treatment. Cells were maintained in a multigas incubator (APMW-36; Astec, Fukuoka, Japan) and 
exposed to hypoxic conditions (1% O2–5% CO2–94% N2) for the indicated times42.
Cellular oxygen consumption and extracellular acidification measurement. Cellular oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR) were detected using the XF Cell Mito 
Stress TestTM and XF Glycolysis Stress TestTM by an Extracellular Flux AnalyzerTM XFp respectively (Agilent 
Technologies, Santa Clara, CA). RCC4 and RCC4-VHL cells (2 × 105) were seeded onto each well of an XFp Cell 
Culture microplate. OCR was assessed in glucose-containing XF base medium according to the manufacturer’s 
instructions. The sensor cartridge for the XFp analyzer was hydrated in a 37 °C non-CO2 incubator a day before 
experiment. For the OCR assay, the sensor cartridge was loaded with 1.5 μM oligomycin (complex V inhibitor) 
into injection port A, 2 μM FCCP into port B, and 0.5 μM rotenone/antimycin A (inhibitors of complex I and 
complex III) into port C. During the sensor calibration, cells were incubated in the 37 °C non-CO2 incubator 
in 180 μl assay medium (XF Base Medium, 5.5 mM glucose, 1 mM pyruvate, and 2 mM l-glutamine, pH 7.4). 
The plate was immediately placed onto the calibrated XFp Extracellular Flux Analyzer for the Mito Stress Test 
(Supplementary Fig. 4). Calculations were as follows:
OCR (basal) = OCR (last rate measurement before oligomycin injection) − OCR (minimum rate measure-
ment after rotenone/antimycin-A injection).
OCR (maximal) = OCR (maximum rate measurement after FCCP injection) − OCR (minimum rate meas-
urement after rotenone/antimycin-A injection).
OCR (non-mitochondrial respiration) = OCR (minimum rate measurement after Rotenone/antimycin-A 
injection)
Proton Leak = OCR (minimum rate measurement after Oligomycin injection) − OCR (non-mitochondrial 
respiration).
For the ECAR assay, the injection port A on the sensor cartridge was loaded with 10 mM glucose. During the 
sensor calibration, cells were incubated in the 37 °C non-CO2 incubator in 180 μl assay medium (XF Base Medium 
and 2 mM l-glutamine, pH 7.4). The plate was immediately placed into the calibrated XFp Extracellular Flux 
Analyzer for the Glycolysis Stress Test. Oligomycin (1 µM) and 2-DG (50 mM) were used for the measurement. 
ECAR was normalized to the total protein/well. ECAR (Glycolysis) = ECAR (maximum rate measurement after 
glucose injection) − ECAR (last rate measurement before glucose injection).
Quantitative RT-PCR analysis (qRT-PCR). Total RNA was extracted from cells using the TaKaRa 
FastPure RNA kit (Takara Bio, Ohtsu, Japan), according to the manufacturer’s instructions. First-strand synthe-
sis and RT-PCR were performed using the One-step SYBR PrimeScript RT-PCR kit (Takara Bio), according to 
the manufacturer’s protocol. Amplification and detection were performed using the Applied Biosystems 7300 
Real-time PCR System (Applied Biosystems, Foster City, CA, USA). PCR primers were purchased from Qiagen. 
The change in expression of each target mRNA was calculated relative to the level of 18 S rRNA44.
Data analysis of RNA-Seq. FASTQ files for RCC4-EV cells (SRR1554431 and SRR1554986) and 
RCC4-VHL cells (SRR1554988 and SRR155499) were obtained from the Sequence Read Archive (https://trace.
ddbj.nig.ac.jp/dra/index_e.html). The quality of sequence data was evaluated by FastQC (http://www.bioinfor-
matics.babraham.ac.uk/projects/fastqc/) after the trimming process by fastx_toolkit v 0.0.14 (http://hannonlab.
cshl.edu/fastx_toolkit/). The human reference sequence file (hs37d5.fa) was downloaded from the 1000 genome 
ftp site (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/phase2_reference_assembly_sequence/), 
and the annotated general feature format (gff) file was downloaded from the Illumina iGenome ftp site (ftp://
igenome:G3nom3s4u@ussd-ftp.illumina.com/Homo_sapiens/NCBI/build37.2/). The human genome index was 
constructed with bowtie-build in Bowtie v.2.2.945. The fastq files were aligned to the reference genomic sequence 
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by TopHat v.2.1.1 with default parameters46. Bowtie2 v2.2.9 and Samtools v.1.3.1 was used with the TopHat pro-
gram47. Estimation of transcript abundance was calculated, and the count values were normalized to the upper 
quartile of the fragments per kilobase of transcript per million fragments mapped reads (FPKM) using Cufflinks 
(cuffdiff) v2.1.148.
Metascape (http://metascape.org/) was used for the gene set enrichment analysis. A gene list for metascape 
analysis was generated using the output from the cuffdiff program, in which 72 genes judged as ‘significantly 
differentially expressed’ (p < 0.05) in cuffdiff output (gene_exp. diff, Supplementary Dataset S1) were contained 
(Supplementary Fig. S3a).
Genes containing Gene Ontology annotations (‘canonical glycolysis’ (GO:0061621) and ‘hypoxia-inducible 
factor-1alpha signaling pathway’ (GO:0097411)) were extracted using Ensembl Biomart49 and sorted by cor-
responding values (common logarithms of ([FPKM of RCC4-EV] + 1)/([FPKM of RCC4-VHL] + 1)) calcu-
lated from the same cuffdiff output file (Supplementary Fig. S3b). The integer one was added to all FPKM values 
because we cannot calculate the logarithm of 0. The histogram was generated using TIBCO Spotfire Desktop 
v7.6.0 with TIBCO Spotfire’s “Better World” program license (TIBCO Spotfire, Inc., Palo Alto, CA, USA) (http://
spotfire.tibco.com/better-world-donation-program/).
Statistical Analysis. All experiments were repeated at least twice and each sample was evaluated in trip-
licate. Representative data, expressed as mean ± SD, are shown. Differences between results were evaluated by 
one-way analysis of variance (ANOVA) or two-way ANOVA, followed by Dunnet’s test for multiple comparisons 
or by the t-test using Prism7Tm. P-values < 0.05 were considered statistically significant.
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